Edrecolomab (Monoclonal Antibody 17-1A): A Viewpoint by Harry Bleiberg

ISSN： 0012-6667

Source： Drugs, Vol.56, Iss.4, 1998-10, pp. : 627-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Edrecolomab (Monoclonal Antibody 17-1A)

By Adkins J.C. Spencer C.M.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 619-626

Adis International

Access to resources Recommend Favorite

Monoclonal antibody–drug conjugates

By Hamann Philip R

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1087-1103

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody “Gold Rush”

Current Medicinal Chemistry, Vol. 14, Iss. 18, 2007-08 ,pp. : 1978-1987

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody Discovery: Sourcing of Monoclonal Antibody Variable Domains

Current Drug Discovery Technologies, Vol. 11, Iss. 1, 2014-01 ,pp. : 3-19

Bentham Science Publishers

Access to resources Recommend Favorite

Carboxylate-Dependent Gelation of a Monoclonal Antibody

By Esue Osigwe Kanai Sonoko Liu Jun Patapoff Thomas Shire Steven

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2478-2485

Springer Publishing Company

Access to resources Recommend Favorite